The Taylor lab Ovarian Cancer Models (OCMs) are patient-derived tumour cell cultures, unfettered by contaminating, genetically normal stromal cells and the microenvironment. OCMs display the hallmark characteristics of HGSOC and retain the unique molecular features of the original tumour. OCMs have extensive proliferative potential, enabling high-resolution cell biology and drug-sensitivity profiling on tumour cells ‘close to the patient’, i.e. without extensive culture and genetic drift. OCMs are clinically annotated, and have been extensively characterised with associated data sets being publicly available (including multi-omics data e.g. exome and RNA sequencing, and single-cell karyotyping). OCMs can also be used to generate PDX, thus enabling in vivo studies of novel therapies. Collectively, this living biobank represents comprehensive platform for basic research and drug development projects (see PMID: 37592171 for a review)
Alternate name:
Ovarian Cancer Model 66-1
Gender:
Female
CRISPR:
No
Production details:
To establish cultures, red blood cells were lysed, the remaining cellular fraction harvested by centrifugation, disaggregated if necessary then plated in OCMI media. Serial passaging and selective detachment eliminated white blood cells and yielded separate tumour and stromal fractions.
Model description:
FIGO 3C; Ascites; TP53 mutation (p.Y163C)
Cat. #:
161890
Provenance and Ownership:
The OCM.66-1 is owned by Cancer Research UK. CancerTools supplies the OCM.66-1 under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing OCM.66-1 directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements.
Cancer types:
Ovarian cancer
Research Fields:
Cancer
Organism:
Human
Tissue:
Ovary. Ovarian/primary peritoneal. NOTE: The precursor of a substantial proportion of HGSOC is likely to be serous tubal intraepithelial carcinoma in the fimbriae of the fallopian tubes
Gender:
Female
Morphology:
Epithelial
Growth properties:
Adherent
Primary citation:
Louisa Nelson et al. 2020. Nat Commun. 13,11(1):822. PMID: 32054838
Initial handling information:
Primaria™ Tissue Culture Flasks
Format:
Frozen
Storage conditions:
Liquid nitrogen (1/2 T75 ISO)
Shipping conditions:
Dry ice
Growth medium:
OCMI (PMID: 26080861; 32054838) + 5% hyclone FBS
Subculture routine:
Split sub-confluent cultures (~90%) 1:2 using 0.25% trypsin. Limit trypsin incubation to 3 mins max, multiple applications of trypsin may be required to remove all the cells from the flask. Trypsin should be neutralised using DMEM containing 20% FBS
Temperature:
37° C
Atmosphere:
5% CO2 & 5% O2
Storage medium:
Bambanker freezing solution
Mycoplasma free:
Yes
Biosafety level:
2
References:
Bethany M Barnes et al. 2021. Genome Med. 1,13(1):140. PMID: 34470661
Camilla Coulson-Gilmer et al. 2021. J Exp Clin Cancer Res. 16,40(1):323. PMID: 34656146
Anya Golder et al. 2022. NAR Cancer. 12,4(4):zcac036. PMID: 36381271
Louisa Nelson et al. 2020. Nat Commun. 13,11(1):822. PMID: 32054838
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
